Botulinum toxin for the treatment of upper gastrointestinal diseases: the future or already the past?
Madaliński
M H
MH
D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004931:Esophageal Achalasia / Q000188:drug therapy*; D006801:Humans; D009566:Nitrates / Q000627:therapeutic use
D018726:Anti-Dyskinesia Agents; D009566:Nitrates; D001905:Botulinum Toxins